ArticleFrontiers in pharmacology2025

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for bimekizumab.

Zhuomiao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.